AR119546A1 - Métodos para purificar anticuerpos - Google Patents

Métodos para purificar anticuerpos

Info

Publication number
AR119546A1
AR119546A1 ARP200102156A ARP200102156A AR119546A1 AR 119546 A1 AR119546 A1 AR 119546A1 AR P200102156 A ARP200102156 A AR P200102156A AR P200102156 A ARP200102156 A AR P200102156A AR 119546 A1 AR119546 A1 AR 119546A1
Authority
AR
Argentina
Prior art keywords
methods
recombinant antibody
purify antibodies
imidazole
antibody molecules
Prior art date
Application number
ARP200102156A
Other languages
English (en)
Inventor
Curtis William Phippen
Neil Alan Watson
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of AR119546A1 publication Critical patent/AR119546A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/38—Flow patterns
    • G01N2030/381—Flow patterns centrifugal chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente se refiere al campo de la producción de moléculas de anticuerpos recombinantes. En particular, se proporcionan métodos para purificar tales moléculas de anticuerpo recombinante en las que se agrega imidazol o un análogo de imidazol durante la elución de la molécula de anticuerpo recombinante a partir de una resina de cromatografía de afinidad, tal como una resina basada en proteína A.
ARP200102156A 2019-08-02 2020-07-31 Métodos para purificar anticuerpos AR119546A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19189841 2019-08-02

Publications (1)

Publication Number Publication Date
AR119546A1 true AR119546A1 (es) 2021-12-29

Family

ID=67658409

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200102156A AR119546A1 (es) 2019-08-02 2020-07-31 Métodos para purificar anticuerpos

Country Status (13)

Country Link
US (1) US20220280887A1 (es)
EP (1) EP4007771A1 (es)
JP (1) JP2022543187A (es)
KR (1) KR20220039744A (es)
CN (1) CN114401984A (es)
AR (1) AR119546A1 (es)
AU (1) AU2020326087A1 (es)
BR (1) BR112021023542A2 (es)
CA (1) CA3142610A1 (es)
IL (1) IL289959A (es)
MX (1) MX2022001349A (es)
SG (1) SG11202112846RA (es)
WO (1) WO2021023619A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7462762B2 (ja) * 2020-01-20 2024-04-05 ウーシー バイオロジクス アイルランド リミテッド アフィニティークロマトグラフィー用の新規な洗浄緩衝液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726293A (en) * 1992-10-02 1998-03-10 The General Hospital Corporation Affinity purification methods involving imidazole elution
US20040063153A1 (en) * 2002-08-12 2004-04-01 Tomas Jelinek Method for isolation of protein complexes using affinity binding
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
ES2671347T3 (es) * 2010-06-21 2018-06-06 Kyowa Hakko Kirin Co., Ltd. Procedimiento para purificar una proteína que utiliza un aminoácido
EP2776466B1 (en) 2011-11-11 2017-08-23 UCB Biopharma SPRL Albumin binding antibodies and binding fragments thereof
UA112203C2 (uk) 2011-11-11 2016-08-10 Юсб Фарма С.А. Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини
GB201208370D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
GB201411320D0 (en) 2014-06-25 2014-08-06 Ucb Biopharma Sprl Antibody construct
GB201506868D0 (en) * 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method for protein purification

Also Published As

Publication number Publication date
BR112021023542A2 (pt) 2022-03-22
KR20220039744A (ko) 2022-03-29
CA3142610A1 (en) 2021-02-11
EP4007771A1 (en) 2022-06-08
IL289959A (en) 2022-03-01
US20220280887A1 (en) 2022-09-08
JP2022543187A (ja) 2022-10-11
AU2020326087A1 (en) 2021-12-16
WO2021023619A1 (en) 2021-02-11
SG11202112846RA (en) 2021-12-30
MX2022001349A (es) 2022-03-25
CN114401984A (zh) 2022-04-26

Similar Documents

Publication Publication Date Title
EA201592192A1 (ru) Способ очистки моноклональных антител
BR112012024956A2 (pt) processo para a purificação de uma proteína de fator de crescimento
UA117575C2 (uk) Антитіло, яке специфічно зв'язується з il-17a та його застосування
BR112018000477A2 (pt) proteína de ligação de imunoglobulina não natural, composição, uso da proteína de ligação de ig não natural, método de purificação de afinidade de imunoglobulinas, método de geração de uma proteína de ligação de imunoglobulina não natural, molécula de ácido nucleico, vetor, célula hospedeira ou um hospedeiro não humano, e método para a produção de uma proteína de ligação de imunoglobulina não natural
EA201490195A1 (ru) Не содержащие аргинина композиции слитого fc-полипептида и способы их применения
WO2013177115A3 (en) Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
AR085138A1 (es) VARIANTES DE Fc Y METODOS PARA SU PRODUCCION
BR112012020254A2 (pt) método para a purificação de anticorpos a partir de uma mistura de proteína e, unidade operacional única.
ECSP10010191A (es) Anticuerpos antimesotelina y usos de los mismos
BR112015027812A2 (pt) processo contínuo de multietapa para purificação de anticorpos
EA201591814A1 (ru) БИСПЕЦИФИЧЕСКИЕ МОЛЕКУЛЫ Fc
MX2016011934A (es) Inmunoglobulina hibrida conteniendo un enlace no-peptidilico.
BRPI0610197B8 (pt) anticorpo de ligação à esclerostina, processo para a produção do mesmo, composição farmacêutica que compreende o dito anticorpo e vetor de clonagem ou expressão
EA201490677A1 (ru) Связывающие антиген cd27l белки
MX2016001601A (es) Separacion de anticuerpos biespecificos y subproductos de produccion de anticuerpos biespecificos utilizando cromatografia de hidroxiapatita.
MX2009008608A (es) Anticuerpos monoclonales anti-cxcl13.
MX2020000288A (es) Cromatografia.
MX2018016121A (es) Preparacion de anticuerpos monoclonales marcados con 212pb.
UA120047C2 (uk) Антигензв'язуючий фрагмент антитіла, який специфічно зв'язується з рецептором інсуліноподібного фактора росту 1 (igf1r)
BRPI0721238A2 (pt) Método de purificação da apolipoproteina a-1
EA202090044A1 (ru) Очистка идуронат-2-сульфатазы
MX2021004404A (es) Metodo para purificar anticuerpo que tiene bajo punto isoelectrico.
EP4349853A3 (en) Novel triple-helical polypeptides lacking binding affinity for the fc domain of immunoglobulin and uses thereof
AR119546A1 (es) Métodos para purificar anticuerpos
BR112014019773A8 (pt) Ligantes para anticorpo e proteína de fusão fc para cromatografia de afinidade